PTGX — Protagonist Therapeutics, Inc. stock price, charts and financials

QT78Protagonist Therapeutics, Inc.

Protagonist Therapeutics, Inc. (NASDAQ: PTGX) is a Healthcare company in the Biotechnology industry. QuoTrend tracks its price, financials, earnings, analyst ratings and insider trades.

Latest market price
150.00
+4.13+2.83%
OverviewShort InterestFilings
PTGXQT78Protagonist Therapeutics, Inc.·NASDAQ
150.00+2.83%

Latest SEC Filings

Form category
Filing Date ▾FormDescriptionFilingDocument
Aug 07, 2026SC 13GBeneficial ownership statement (passive)
Aug 05, 2026S-8Registration of employee benefit securities
Aug 05, 2026S-8 POSS-8 POS
Aug 05, 202610-QQuarterly report
Aug 05, 2026S-8 POSS-8 POS
Aug 05, 2026S-8 POSS-8 POS
Aug 05, 2026S-8 POSS-8 POS
Aug 05, 2026S-8 POSS-8 POS
Aug 05, 2026S-8 POSS-8 POS
Aug 05, 2026S-8 POSS-8 POS
Aug 05, 20268-KCurrent report
Aug 05, 2026S-8 POSS-8 POS
Aug 05, 2026S-8 POSS-8 POS
Aug 05, 2026S-8 POSS-8 POS
Aug 05, 2026S-8 POSS-8 POS
Jun 25, 20264Statement of changes in beneficial ownership
Jun 18, 20268-KCurrent report
Jun 11, 20264Statement of changes in beneficial ownership
Jun 01, 20264Statement of changes in beneficial ownership
May 14, 20264/AStatement of changes in beneficial ownership (amended)
May 12, 2026SC 13GBeneficial ownership statement (passive)
May 12, 20264Statement of changes in beneficial ownership
May 11, 20264Statement of changes in beneficial ownership
May 05, 20268-KCurrent report
May 05, 202610-QQuarterly report
#1 / 25 of 304
Page
▼
/ 13